CONSOLIDATED STATEMENTS OF PERPETUAL PREFERRED STOCK AND EQUITY - USD ($) $ in Millions	Total	Impact of adoption of ASU 2020-06	Common Stock	Convertible Preferred Stock, net	Convertible Preferred Stock, net Impact of adoption of ASU 2020-06	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital Impact of adoption of ASU 2020-06	Retained Earnings	Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2022	8,000,000
Beginning balance at Dec. 31, 2022	$ 151
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of perpetual preferred stock, net (in shares)	6,000,000
Issuance of perpetual preferred stock, net	$ 103
Accretion of perpetual preferred stock to redemption value	$ 30
Ending balance (in shares) at Dec. 31, 2023	14,000,000
Ending balance at Dec. 31, 2023	$ 284
Common stock, beginning balance (in shares) at Dec. 31, 2022			73,000,000
Preferred stock, beginning balance (in shares) at Dec. 31, 2022				142,000,000
Beginning balance at Dec. 31, 2022	556		$ 0	$ 426		$ (7)	$ 88		$ 43	$ 6
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	17								17
Change in fair value of derivative instruments, net of tax	(2)									(2)
Accretion of perpetual preferred stock to redemption value	(30)								(30)
Issuance of convertible preferred stock, net	2			$ 2
Dividends on perpetual preferred stock	(5)								(5)
Issuance of common stock (in shares)			3,000,000
Issuance of common stock	44						44
Exercise of stock options (in shares)			1,000,000
Exercises of stock options	3						3
Stock-based compensation expense	3						3
Common stock, ending balance (in shares) at Dec. 31, 2023			77,000,000
Preferred stock, ending balance (in shares) at Dec. 31, 2023				142,000,000
Ending balance at Dec. 31, 2023	588	$ 0	$ 0	$ 428	$ 2	(7)	138	$ (2)	25	4
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of perpetual preferred stock to redemption value	$ 40
Ending balance (in shares) at Dec. 31, 2024	14,000,000
Ending balance at Dec. 31, 2024	$ 324
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	3								3
Change in fair value of derivative instruments, net of tax	0
Accretion of perpetual preferred stock to redemption value	(40)						(29)		(11)
Dividends on perpetual preferred stock	(9)								(9)
Exercise of stock options (in shares)			1,000,000
Exercises of stock options	3						3
Stock-based compensation expense	$ 4						4
Common stock, ending balance (in shares) at Dec. 31, 2024	78,000,000		78,000,000
Preferred stock, ending balance (in shares) at Dec. 31, 2024	142,000,000			142,000,000
Ending balance at Dec. 31, 2024	$ 549		$ 0	$ 430		(7)	114		8	4
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of perpetual preferred stock to redemption value	$ 36
Ending balance (in shares) at Dec. 31, 2025	14,000,000
Ending balance at Dec. 31, 2025	$ 360
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40								40
Change in fair value of derivative instruments, net of tax	(4)									(4)
Accretion of perpetual preferred stock to redemption value	(36)						(25)		(11)
Dividends on perpetual preferred stock	(37)								(37)
Acquisition of business and other assets (in shares)			1,000,000
Acquisition of business and other assets	10						10
Exercise of stock options (in shares)			1,000,000
Exercises of stock options	2						2
Stock-based compensation expense	$ 4						4
Common stock, ending balance (in shares) at Dec. 31, 2025	79,000,000		80,000,000
Preferred stock, ending balance (in shares) at Dec. 31, 2025	141,989,676			142,000,000
Ending balance at Dec. 31, 2025	$ 528		$ 0	$ 430		$ (7)	$ 105		$ 0	$ 0